Quest Diagnostics Completes Acquisition of Clinical Outreach Operations of Dignity Health
News Jul 05, 2013
Quest Diagnostics announced that it has completed the previously announced acquisition of lab-related clinical outreach service operations of Dignity Health, a hospital system based in California.
Quest Diagnostics will perform testing for the acquired operations through its clinical laboratories in West Hills and Sacramento, Calif., and Las Vegas, Nevada. The acquisition includes patient service centers and associated business in parts of California and Nevada. Dignity Health's hospital-based laboratories are not included in the sale. Additional terms were not disclosed.
Quest Diagnostics continues to expect the transaction to be neutral to adjusted earnings in 2013 and modestly accretive to earnings per share in 2014. The company also expects it to contribute about half a percentage point to consolidated revenues annually.
The acquisition, which is the company's third of a laboratory business in 2013, is consistent with the five-point strategy described by Quest Diagnostics late last year. This strategy includes delivering disciplined capital deployment and driving one to two percent in growth per year through strategically aligned fold-in acquisitions. In May, the company announced it had acquired the toxicology and clinical laboratory business of medical center operator Concentra, a subsidiary of Humana Inc. In January, the company completed the acquisition of the clinical and anatomic-pathology outreach laboratory businesses of Massachusetts-based UMass Memorial Medical Center.
Screening for Disease or Toxins in a Drop of BloodNews
Scientist have developed a multinozzle emitter array (MEA), a silicon chip that can dramatically shorten the time it takes to identify proteins, peptides, and other molecular components within small volumes of biological samples.READ MORE
Diabetic Ketoacidosis Assay Collaboration Between Ortho Clinical Diagnostics and EKF DiagnosticsNews
EKF’s Beta-Hydroxybutyrate LiquiColor® Assay for detection of predominant ketone body now available on Ortho’s VITROS® 4600 Chemistry System and VITROS® 5600 Integrated System.READ MORE
Fabric Genomics Partners to Improve Pediatric CareNews
Partnerships with Genomics England, Rady Children's Institute for Genomic Medicine, and The Utah Genome Project demonstrate diagnostic utility of Fabric Genomics' algorithm-based genome analysis.READ MORE